Ken Griffin Mannkind Corp Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mannkind Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 133,300 shares of MNKD stock, worth $487,878. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,300
Previous 64,000
108.28%
Holding current value
$487,878
Previous $321,000
55.14%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding MNKD
# of Institutions
248Shares Held
161MCall Options Held
1.24MPut Options Held
179K-
Black Rock Inc. New York, NY22.6MShares$82.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$66.5 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$39.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$27.9 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$25.7 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $942M
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...